Fiera Capital (Canada)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $51.3M | Buy |
|
|||||
|
2024
Q1 | $53.8M | Sell |
|
|||||
|
2023
Q4 | $63.1M | Buy |
|
|||||
|
2023
Q3 | $57.4M | Buy |
|
|||||
|
2023
Q2 | $38.4M | Sell |
|
|||||
|
2023
Q1 | $43.8M | Sell |
|
|||||
|
2022
Q4 | $47.7M | Sell |
|
|||||
|
2022
Q3 | $36.9M | Sell |
|
|||||
|
2022
Q2 | $38.6M | Sell |
|
|||||
|
2022
Q1 | $36.8M | Buy |
|
|||||
|
2021
Q4 | $4.73M | Buy |
|
|||||
|
2021
Q3 | $4.12M | Sell |
|
|||||
|
2021
Q2 | $56.1M | Sell |
|
|||||
|
2021
Q1 | $52.5M | Sell |
|
|||||
|
2020
Q4 | $62M | Sell |
|
|||||
|
2020
Q3 | $54M | Buy |
|
|||||
|
2020
Q2 | $60.9M | Sell |
|
|||||
|
2020
Q1 | $41.8M | Buy |
|
|||||
|
2019
Q4 | $32.4M | Sell |
|
|||||
|
2019
Q3 | $27.3M | Buy |
|
|||||
|
2019
Q2 | $1.63M | Buy |
|
|||||
|
2019
Q1 | $1.2M | Buy |
|
|||||
|
2018
Q4 | $842K | Buy |
|
|||||
|
2018
Q3 | $789K | Buy |
|
|||||
|
2018
Q2 | $473K | Buy |
|
|||||
|
2018
Q1 | $337K | Buy |
|
|||||
|
2017
Q4 | $216K | Sell |
|
|||||
|
2017
Q3 | $233K | Sell |
|
|||||
|
2017
Q2 | $601K | Buy |
|
|||||
|
2017
Q1 | $572K | Buy |
|
|||||
|
2016
Q4 | $528K | Sell |
|
|||||
|
2016
Q3 | $671K | Sell |
|
|||||
|
2016
Q2 | $568K | Buy |
|